Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/CRISPR Therapeutics

CRISPR Therapeutics

Series A
Basel, SwitzerlandFounded 2013Apr 2014
Healthtech

CRISPR Therapeutics raised €23M in a Series A round in Apr 2014. The company is based in Basel, Switzerland. Investors in the round: Versant Ventures. Data as of Nov 2026.

← CRISPR Therapeutics
Amount raised
€23M
€22,500,000
Native amount
22,500,000 EUR
Stage
Series A
series a
Investors
1

Provenance & confidence

Unverified
Amount

Reported in EUR — no conversion. €23M

High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Versant Ventures
Date
Apr 2014
Round type
series a
Amount (EUR)
€23M

Other rounds

same company